Vertex Pharmaceuticals (VRTX) stock

Last close 547.89 USD (Nov 10, 2026), on the day −0.5 %.

• Sector: Healthcare, Biotechnology.
• Market cap: 139.7B USD.
• P/E: 35.4. Forward P/E: 27.7.
• Over 52 weeks: low 421.03 USD, high 558.88 USD, price change +30.1 %.
• Analysts' average 12-month target from Yahoo Finance: 592 USD (28 analysts). Not our estimate.

Earnings

• Feb 11, 2027: EPS not yet, estimate 4.10
• Nov 2, 2026: EPS 4.76, estimate 4.78
• Aug 3, 2026: EPS 4.73, estimate 4.75
• May 4, 2026: EPS 4.47, estimate 4.31
• Feb 12, 2026: EPS 5.03, estimate 5.15
• Nov 3, 2025: EPS 4.80, estimate 4.58

Which large investors hold it

• Tweedy, Browne – 1.1 % of the portfolio
• Ray Dalio – 0.0 % of the portfolio

In baskets

• Biotech

Similar companies: ARGX · BMRN · BNTX · EXEL · INCY · MRNA · REGN